Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma.

Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma.

<h4>Objectives</h4>Post-chemoradiotherapy (CRT) FDG PET is a useful prognosticator of esophageal cancer. However, debate on the diverse criteria of previous publications preclude worldwide multicenter comparisons, and even a universal practice guide. We aimed to validate a simple qualita...

Full description

Bibliographic Details
Main Authors:	Yung-Cheng Huang, Shau-Hsuan Li, Hung-I Lu, Chien-Chin Hsu, Yu-Ming Wang, Wei-Che Lin, Chao-Jung Chen, Kuo-Wei Ho, Nan-Tsing Chiu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0210055

Similar Items

Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
by: Xin Xu, et al.
Published: (2021-07-01)

F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
by: Seokmo Lee MD, PhD, et al.
Published: (2021-07-01)

Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Tai-Jan Chiu, et al.
Published: (2018-01-01)

18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making.
by: Maarten C J Anderegg, et al.
Published: (2015-01-01)

Baseline FDG Uptake And Peripheral Lymphocyte-Monocyte Ratio For Predicting Chemoradiotherapy Response In Patients With Esophageal Squamous Cell Carcinoma
by: Wang C, et al.
Published: (2019-10-01)

Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using <sup>18</sup>F-FDG PET Images
by: Yuji Murakami, et al.
Published: (2021-06-01)

Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal Squamous cell carcinoma
by: Weng-Yoon, Shum, et al.
Published: (2011)

Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with18F-FDG PET Radiomics Based Machine Learning Classification
by: Beukinga, R.J, et al.
Published: (2022)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01)

Appropriateness criteria of FDG PET/CT in oncology
by: Archi Agrawal, et al.
Published: (2015-04-01)

The treatment outcome of definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Mahdi Seilanian Toosi, et al.
Published: (2007-10-01)

Subclinical Lesions of the Primary Clinical Target Volume Margin in Esophageal Squamous Cell Carcinoma and Association With FDG PET/CT
by: Dali Han, et al.
Published: (2019-04-01)

Chemoradiotherapy and Increased Prescription Dose in Esophageal Squamous Cell Cancer: A Retrospective Study
by: Xiaofen Pan, et al.
Published: (2021-01-01)

Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
by: Shau-Hsuan Li, et al.
Published: (2021-06-01)

The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma
by: Yi Wen Mo, et al.
Published: (2021-04-01)

The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2018-08-01)

Areca nut is associated with younger age of diagnosis, poor chemoradiotherapy response, and shorter overall survival in esophageal squamous cell carcinoma.
by: Chang-Han Chen, et al.
Published: (2017-01-01)

A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation
by: Yimin Li, et al.
Published: (2020-10-01)

Predictive value of neutrophil-lymphocyte ratio in preoperative neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: XIONG Kai, et al.
Published: (2021-01-01)

The Relationship between Brown Adipose Tissue Activity and Neoplastic Status: an <sup>18</sup>F-FDG PET/CT Study in the Tropics
by: Huang Yung-Cheng, et al.
Published: (2011-12-01)

Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy
by: Wan-Ting Huang, et al.
Published: (2019-11-01)

Preoperative Chemoradiotherapy followed by Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: a Single Center Experience in Southern Taiwan
by: Chien-Ming Lo, et al.
Published: (2014-12-01)

The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
by: Yen-Hao Chen, et al.
Published: (2018-01-01)

FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
by: Edouard Depardon, et al.
Published: (2018-01-01)

Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.
by: Yen-Wen Wu, et al.
Published: (2014-01-01)

Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
by: Ying-Ying Xu, et al.
Published: (2021-07-01)

Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma
by: Sungmin Jun, et al.
Published: (2018-09-01)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
by: Mingqiu Chen, et al.
Published: (2018-08-01)

Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC)
by: Cselik, Z., et al.
Published: (2021)

FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
by: Nan-Chin Lin, et al.
Published: (2021-07-01)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
by: Yang Yang, et al.
Published: (2020-08-01)

Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
by: Jingzhen Shi, et al.
Published: (2020-07-01)

Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
by: Zhu S, et al.
Published: (2016-10-01)

Dose escalation guided by 18F-FDG PET/CT for esophageal cancer
by: Bingjie Fan, et al.
Published: (2021-06-01)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2020-01-01)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Ding T, et al.
Published: (2021-10-01)

Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
by: Shiliang Liu, et al.
Published: (2021-06-01)

The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
by: Christos Sachpekidis, et al.
Published: (2021-10-01)

Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas
by: Dequanter D, et al.
Published: (2015-08-01)

Cannot write session to /tmp/vufind_sessions/sess_4sfavjf683gni0767cq5igajnf